Linda Zipp, MD in Rio Rancho, NM - Pediatrics

Linda Zipp, MD is a Pediatrics physician based in Rio Rancho, New Mexico. Linda Zipp is licensed to practice in New Mexico (license number 86154) and her current practice location is 4005 High Resort Blvd Se, Pmg High Resort 4005, Rio Rancho, New Mexico. She can be reached at her office (for appointments etc.) via phone at (505) 462-6000.

NPI number for Linda Zipp is 1497849889 and her current mailing address is Po Box 26666, Phs Provider Enrollment, Albuquerque, New Mexico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1497849889.

Contact Information

	Linda Zipp, MD
	4005 High Resort Blvd Se, Pmg High Resort 4005, Rio Rancho, NM 87124-5906
	(505) 462-6000
	(505) 462-6006

Physician's Profile

Full Name	Linda Zipp
Gender	Female
Speciality	Pediatrics
Location	4005 High Resort Blvd Se, Rio Rancho, New Mexico
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1497849889
Provider Enumeration Date: 10/03/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Linda Zipp such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1497849889	NPI	-	NPPES
37150	Medicaid	NM

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	86154 (New Mexico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Linda Zipp is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Linda Zipp, MD Po Box 26666, Phs Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-5356	Linda Zipp, MD 4005 High Resort Blvd Se, Pmg High Resort 4005, Rio Rancho, NM 87124-5906 Ph: (505) 462-6000

News Archive

FDA urged to prohibit menthol in tobacco products

Today the American Legacy Foundation(R) (Legacy) urged the Food and Drug Administration (FDA) to prohibit menthol in cigarettes and other flavored tobacco products as one of its first priorities related to the Family Smoking Prevention and Tobacco Control Act (the Act).

Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.

Today's Opinions: The collective benefits of the new health law; Patient safety; Legalizing marijuana

If President Obama's reform package remains intact, [cancer patient Michelle] Mindlin will be able to shop for potentially more affordable coverage in an insurance "exchange" where companies will be prevented from turning people away because of their medical history. But that doesn't go into effect until 2014. And it might not happen at all if the courts overturn a requirement that nearly everyone buy health insurance (David Lazarus, 12/21).

Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia

Alkermes plc today announced the initiation of a phase 3 clinical trial of ALKS 9070 for the treatment of schizophrenia. ALKS 9070, a proprietary Alkermes molecule, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY for the treatment of a number of central nervous system disorders.

Scientists identify sugar molecule that reduces inflammatory response and COPD progression

Using a mouse model, scientists from the RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD).

Pediatrics Doctors in Rio Rancho, NM

Kristina Gutierrez-barela, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1721 Rio Rch Dr Se, Rio Rancho, NM 87124 Phone: 505-896-8600 Fax: 505-896-8612
Dr. Chelsea Jean Sanchez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2411 Cabezon Blvd Se Ste 103, Rio Rancho, NM 87124 Phone: 505-272-1088 Fax: 505-272-6845
James S Bruce, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4005 High Resort Blvd Se, Pmg High Resort 4005, Rio Rancho, NM 87124 Phone: 505-462-6000 Fax: 505-462-6006
Dr. Michael A Klein, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4005 High Resort Blvd Se, Pmg Rio Rancho High Resort 4005, Rio Rancho, NM 87124 Phone: 505-462-6000 Fax: 505-462-8686
John M Good, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1721 Rio Rancho Dr Se, Rio Rancho, NM 87124 Phone: 505-896-8600 Fax: 505-896-8612
Philip J Leonardelli, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1704 Southern Blvd Se, Rio Rancho, NM 87124 Phone: 505-994-3256 Fax: 603-947-3608
Dr. Simone Green, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4005 High Resort Blvd Se, Rio Rancho, NM 87124 Phone: 505-462-6000 Fax: 505-462-8686

Linda Zipp, MD - Pediatrics in Rio Rancho, NM